Categories
All News Coronavirus News

Opportunities for technological Upgradation to Drive the global Surgical Marking Pens Market

Surgical Marking Pens: Introduction

Surgical marking instruments are specifically used during surgical procedures. They are widely used in healthcare facilities throughout the world in different forms. The surgical marking pens are used on the patient’s body before the surgical procedure to mark the boundaries and perform any major incision. The concept of marking on the surgical site is the most commonly followed practice by healthcare professionals worldwide for the ease of the procedure. Surgical marking pens are widely accepted due to its compatibility and easy-to-use behavior. Surgical marking instruments are essential for making surgical procedure efficient and accurate.

For more insights into the Market, request a  sample of this report @ https://www.persistencemarketresearch.com/samples/22930

High Adoption of Surgical Marking Pens

Surgical marking pens have different properties such as clear visibility, biocompatibility, non-toxic behavior and sterile factor, including operating on the correct side of the patient and/or the correct anatomical location. Surgical pens compete with surgical markers in terms of adoption at few institutional levels, but surgical marking pens are comparatively more prevalent than surgical marking markers. Surgical marking pens are ideal for a wide set of operations as the new advancements in them offer surgeons to prepare effectively whilst minimizing the risk. The common remarks observed in assessing the marking pens are that they are latex free, sterile or non-sterile, tip type, single use convenience and with large ink reservoir. The gentian violet ink has antifungal properties, which is used in the majority of surgical marking pen.

For Information On The Research Methodology request here @ https://www.persistencemarketresearch.com/methodology/22930

Factors Driving and Restraining the Surgical Marking Pens Market

The global market for surgical marking instruments is driven by increasing surgical procedures and trauma injuries. Technological advancements and availability of product variant in the market is likely to increase the revenue over the forecast period. They are used in pre-operative prepping and are ideal for use in plastic surgery and orthopedic surgery, and increasing surgical procedures all over the world and high adoption of surgical marking pens by the healthcare professionals are major factors driving the growth of the surgical marking pens market. In 2015, over 4 million procedures of plastic surgery were performed in the U.S. alone, chin implants increased by 76%. But when population is accounted for, South Korea tops the list of plastic surgery globally. A wide range of surgical marking pens are available in the market with different properties and at low cost, which significantly increase the demand for surgical marking pens. Likewise, the high adoption of surgical marking pen is due to its visibility and sharpness. However, risk and infection associated with surgical marking instruments can lead to cross-contamination as well as incorrect site marking and lack of guidelines are some of the factors that may hamper the growth of the surgical marking pens market.

To receive extensive list of important regions, Request TOC here @ https://www.persistencemarketresearch.com/toc/22930

Surgical Marking Pens in Hospitals

Hospitals, Ambulatory Surgical Centers and Specialty Clinics are the major end-use segments in the surgical marking pens market. Hospital segment contributes maximum share in the global surgical marking pens market, as large number of surgical procedures are performed in hospitals on a regular basis. Also, high demand for surgical marking pens is observed in the Ambulatory Surgical Centers due to its regular use in surgical procedures.

Regional Outlook

North America followed by Europe will continue to dominate the global surgical marking pens market in terms of revenue over the forecast period, owing to high awareness and adequate healthcare facilities the region. Furthermore, increasing prevalence of chronic disease is expected to result in higher demand for the surgical procedure over the forecast period. Asia Pacific (exc. China) is expected to have significant growth over the forecast period due to improving healthcare infrastructure and increasing awareness among healthcare professionals as well as patients.

Competition Outlook

Examples of some of the players identified in the global surgical marking pens market are Viscot Medical, LLC Aspen Surgical (Hill Rom), Cardinal Health, Viomedex, First Aid Bandage Company (FABCO), Accu-line Products, Inc., Surgmed, and Ansell Sandel Medical Solutions LLC, among others. Major companies hold a high share in the market due to their strong presence, but are continuously being challenged by the new manufacturers. The market is distributed according to the regional preferences and adoption rate of the surgical pens in various services.

Majority of surgical marking instrument manufacturers offer surgical marking pens.

surgical marking pens market

Small-Scale Manufacturers/Providers Medium-Scale Manufacturers/Providers Large-Scale Manufacturers/Providers
  • Purple Surgical
  • Dispomedica
  • McKesson Medical-Surgical Inc.
  • First Aid Bandage Company (FABCO)
  • KOKEN CO., LTD.
  • FARBTEK™
  • MB Holding (3teks)
  • Accu-line Products, Inc.
  • Ansell Sandel Medical Solutions LLC
  • Viscot Medical, LLC
  • Viomedex
  • Surgmed
  • Aspen Surgical (Hill Rom)
  • Cardinal Health

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Tanvi Birajdar
Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com

Categories
All News Coronavirus News

Extensive Research Driving the Cone Beam Computed Tomography Extremity Scanner Market

Point-of-care diagnostic has increased the demand for cone-beam computed tomography extremity scanner. A cone beam computed tomography extremity scanner is specially designed according to different human extremities and maxillofacial area. The cone beam computed tomography extremity scanner uses a cone beam radiating from an X-ray source in the shape of a cone that covers large volume with one single rotation. The X-ray images are reconstructed by using an algorithm to make high-resolution images. These high-resolution images can assist with accurate diagnosis and treatment planning. The cone beam computed tomography extremity scanner provides better patient positioning and patient comfort due to its compact size, non-invasive nature and use of low dose contrast agent.

For more insights into the Market, request a  sample of this report @ https://www.persistencemarketresearch.com/samples/22933

The Success of Cone Beam Computed Tomography Extremity Scanner

In the recent years, the demand for cone beam computed tomography technology has increased steeply and the prime reason is affordability of advanced extremity CBCT scanner units. Cone beam computed extremity scanner technologies determine the health issue with absolute clarity thus, several healthcare professionals and imaging specialists are keenly interested in this device. The effectiveness and efficiency of cone beam computed tomography extremity scanner in medical interventions is driving the overall market. Cone beam computed tomography extremity scanner is an ideal solution for the radiology centers, hospital orthopedic departments, and point-of-care diagnosis because of its self-shielded design, and standard power requirements and small footprint.

For Information On The Research Methodology request here @ https://www.persistencemarketresearch.com/methodology/22933

Cone Beam Computed Tomography Extremity Scanner Market Assessment by End Users

cone beam computed tomography extremity scanner market

Factor Driving the Cone Beam Computed Tomography Extremity Scanners Market

The growth of the market is primarily driven by the factors such as increasing demand for point-of-care diagnostics, new product launches, and their acceptance in dental and orthopedics field. In addition, low cost of the device than the traditional device, expanding applications of cone beam computed tomography and agreements and collaborations among market players are also adding up to the growth of the market. However, lack of dose and image quality assessment standardization and limited reimbursement scenario may hinder the growth of the cone beam computed tomography extremity scanner market.

To receive extensive list of important regions, Request TOC here @ https://www.persistencemarketresearch.com/toc/22933

High Adoption in the Dental and Orthopedic Areas

Cone beam computed tomography extremity scanners have various advantages, e.g., dose reduction, reducing waiting lists, shorter appointment slots, improving patient flow and others. These devices are specifically designed to perform upper and lower extremity 3D imaging, including weight-bearing extremity imaging. From the past several years, the adoption of advanced cone beam computed tomography extremity scanner is increased in dental and orthopedic areas due to their specialized requirement for the human imaging diagnosis and treatment.

Regional Market Outlook

North America leads the cone beam computed tomography extremity scanner market reasons being technological advancement, new product innovations, and early treatment adoption. Europe is the second leading market for cone beam computed tomography extremity scanner due to development activities and presence of large research base. The Asia Pacific market of cone beam computed tomography extremity scanner is also expected to grow at a higher rate owing to improving healthcare infrastructure, increasing prevalence of orthopedic disorders, partnerships/collaborations among key players, and growing disposable incomes in developing countries (such as China and India).

Competition Outlook

Examples of some of the key players identified in the global cone beam computed tomography extremity scanner market are PLANMED OY, Carestream Health, and CurveBeam, among others. The synergies between the companies for product innovation, distribution is presenting immediate growth impact rather than acquisitions and mergers. However, increase in adoption rate among healthcare professionals and cost effectiveness are some of the factors offering global opportunities to its manufacturers to manufacturer high-grade cone beam computed tomography extremity scanners.

Small-Scale Manufacturers/Providers Medium-Scale Manufacturers/Providers Large-Scale Manufacturers/Providers
  •   CurveBeam
  • Prexion
  • PLANMED OY
  • Carestream Health.
  • J. MORITA CORP

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Tanvi Birajdar
Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com

Categories
All News Coronavirus News

The Ambulance Cots Market to Witness an Impulse between 2018 and 2026

Ambulance Cots are emergency patient-handling devices designed for transporting patients in a ground-based ambulance. The ambulance cots are for professional use by a minimum of two trained operators. Ambulance Cots help to reduce the stress and strain to EMS personnel during the loading and unloading of a cot. Ambulance cot device includes a base for mounting to an emergency vehicle deck, a rail mounted for linear movement along the base, and an arm, which is configured to engage a cot, mounted for linear movement along the rail from a retracted position to an extended position.

For more insights into the Market, request a  sample of this report @ https://www.persistencemarketresearch.com/samples/23008

Ambulance Cots Market: Drivers and Restraint

Increase in the number of road accidents and rising geriatric & bariatric population are driving the global ambulance cots market. In addition, the surge in advancements in technology, such as automation in emergency stretchers is also expected to drive ambulance cots market. Factors such as favorable government policies, increase in research and development and technological advancement also boost the growth of ambulance cots market. On the other hand, lack of training provided to the caregivers, high cost of devices, and its maintenance limits the growth of global ambulance cots market.

For Information On The Research Methodology request here @ https://www.persistencemarketresearch.com/methodology/23008

Ambulance Cots Market: Segmentation

The global market for Ambulance Cots is segmented by product type, end user, and geography:

  • Based on Product type, Ambulance Cots is segmented into following:
    • Manual
    • Powered
  • Based on End User, Ambulance Cots is segmented into following:
    • Fire Ambulance
    • Disaster Ambulance
    • Hospital Ambulance
  • Based on Geography, Ambulance Cots is segmented into
    • North America
    • Latin America
    • Europe
    • Asia Pacific excluding China
    • China
    • The Middle East & Africa

To receive extensive list of important regions, Request TOC here @ https://www.persistencemarketresearch.com/toc/23008

Ambulance Cots Market: Overview

Powered ambulance cots are recommending as the replacement to the existing manual cots. While power-assisted cots have been shown to reduce back injuries, there is still a lifting component involved in loading the cot into the ambulance. The Emergency Medical Service industry is already moving towards a power loading capability, and purchase of a power-assist cot without some sort of power loading capability would require a significant further expenditure in the near future. Injury reduction benefits due to its self-loading characteristics fuel the growth of ambulance cots market. Moreover, technological advancements in an ambulance related equipment market are expected to offer lucrative opportunities for the ambulance cots market growth during the forecast period.

According to the Centers for Disease Control and Prevention (CDC), the rates of musculoskeletal injuries from overexertion in healthcare occupations are highest in all the U.S. Similarly, as per the reports_bk_01_01_2020 of Bureau of Labor Statistics (BLS), the rate of overexertion injuries averaged across all industries was 33 per 10,000 full-time workers in 2014.

Based on Product type, Ambulance Cots is segmented into manual and powered.

Based on the end user, Ambulance Cots market is classified into Fire Ambulance, Disaster Ambulance And Hospital Ambulance.

Ambulance Cots Market: Region-wise Outlook

Depending on geographic regions, global ambulance cots market is segmented into six key regions viz. North America, Latin America, Europe, Asia Pacific excluding China, China and Middle East & Africa. North America followed by Europe will continue to dominate the global Ambulance Cots market in term of revenue. Furthermore, increasing adaptation of powered ambulance cots is expected to result in higher demand for overall ambulance cots market globally during the forecast period.  Asia Pacific is expected to be the fastest growing region in global Ambulance Cots market due to government initiatives for improving the quality of patient care and decent work culture for caregivers employed in healthcare settings.

Ambulance Cots Market: Key Market Participants

The key market players in the global Ambulance Cots market include Ferno EMS Stryker Corporation and others. Most of the companies sell their products through the medical equipment distributors that operate in different regions and therefore account for substantial competition with respect to the distribution network and market presence.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Tanvi Birajdar
Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com

Categories
All News Coronavirus News

Bone Fixation Devices Market to Witness Rise in Revenues During the Period 2018 – 2026

Bone fixation devices are meant to carefully stabilize and support the broken bone until it gets its natural strength to handle load and basic movement. Earlier practices highlights the use of casts and splints to support and stabilize the bone externally, which had many setbacks, as it only offered minimal fixation of the bone externally . As the arrival of improved sterile surgical procedures helped different bone fixation devices to be used in different bone targets, the adoption of bone fixation devices rose to acceptance because of the availability of both internal and external methods. Internal bone fixation devices are meant to be an invasive alternative for the rest in which different components like nails, plates, screws and wires are included. Bone fragments are then aligned to its natural form for further recovery.

For more insights into the Market, request a  sample of this report @ https://www.persistencemarketresearch.com/samples/23017

External bone fixation devices are used in procedures which includes pins or wires that is inserted percutaneously and hold bone together via an external scaffold. It is mainly used for open fractures to prevent contamination and providing the ideal provisional alignment of bones in multiple trauma cases. It also performs definitive treatment in pelvic fixation, open long bone fractures and periarticular factures.

Bone Fixation Devices Market: Market Dynamics

Strong growth of traditional compatible materials like stainless steel and titanium used in different internal fixation devices, which shows strong and durable character, fixed choices of different materials like cobalt and chromium is also available in particular products. Internal fixation devices provides a shorter hospital stay according to its procedure, also reduces the incidence of nonunion and malunion which are forms of improper healing of broken bones which promotes the acceptance of bone internal fixation devices. While some attention has focused on the prospect that cancer could develop near a long-term implant, there is little indication documenting the risk but with much probability. Further, the continuous growing orthopedic market, rising geriatric population, increasing public awareness and continuous R&D also supports the market.

For Information On The Research Methodology request here @ https://www.persistencemarketresearch.com/methodology/23017

Various key developments such as product advancements and launches, mergers and acquisitions by the bone fixation devices manufacturers are fuelling the growth of bone fixation devices market. However, stringent regulations may obstruct the growth of bone fixation market. In addition, high cost of certain bone fracture surgeries and inadequate reimbursement policies for bone fixation may also hamper the growth of global bone fixation devices market.

Bone Void Fillers market: Segmentation

By Key Product Type:

  • Internal Fixation Devices
    • Component
      • Pins
      • Wires
      • Plates
      • Screws
  • External Fixation Devices
    • Tubular
    • Circular
    • Hybrid
      • By component
        • Pins
        • Pin clamps
        • Rings
        • Connecting rods

By Material type

  • Stainless-steel
  • Titanium
  • Others

By Patient Anatomy Type:

  • Upper Extremity
  • Lower Extremity
  • Others

By End Users:

  • Hospitals
  • Specialized Clinics
  • Ambulatory Surgical Centers

The bone fixation devices market is filled with novel materials claiming their properties to process treatment of bone fractures.

To receive extensive list of important regions, Request TOC here @ https://www.persistencemarketresearch.com/toc/23017

Geographically, the market for Bone Void Fillers can be segmented into six regions – North America, Latin America, Europe, Asia Pacific excluding China, Middle East & Africa and China.  North America dominates the global bone fixation devices market owing to the advanced bone fixation procedures in the region and favorable reimbursement scenario. Europe represents the next leading market with Germany, Italy, U.K. and France holding the major share of bone fixation devices market. However, Asia-Pacific is expected to represent a high growth rate in the coming years due to the increasing public awareness, improving access to healthcare facilities and rising healthcare infrastructure with rise in population observed there’s a greater probable chance for traumatic cases. MEA represents the least market share globally in the bone fixation devices market and is projected to observe change due to healthcare advancements. China holds a major share of domestic players which restricts the market from growing globally, but provides a fair forecast share in coming years.

Some major key players of bone fixation devices market include Zimmer Biomet, Medtronic, Arthrex Inc., DePuy Synthes, Stryker, Atlantic Surgical, Treu Instrumente, Orthofix, Integra Life Science, Bonesupport AB, Osteomed, Wright Medical and others.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Tanvi Birajdar
Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com

Categories
All News Coronavirus News

Increasing Consumer Awareness to Fuel Adoption of Rubella Treatment Market

Rubella is the contagious viral infection of the respiratory system. Rubella is also known as German measles. Rubella is not similar to measles, although they have similar characteristics such as red rushes, but they are caused by a different virus. Rubella virus causes joint pain, low-grade fever, sore throat and skin rash. About 25% to 50% of people infected with rubella virus do not experience any symptoms. Rubella virus spreads through the air or by close contact. It is usually spread when the person directly comes in contact with an infected person’s respiratory secretion such as mucus.

For more insights into the Market, request a  sample of this report @ https://www.persistencemarketresearch.com/samples/23029

Rubella can cause serious problems including the arthritis and bleeding problems. Rubella infection very serious during pregnancy, it can cause a variety of birth defects & miscarriage.  Most serious problems occur because of rubella is harm to a baby. There is no specific treatment available for rubella. Rubella vaccination is recommended for prevention of rubella infection. Unvaccinated ladies face 90% chances of the fetus having congenital rubella syndrome. Symptomatic treatment is available to reduce the risk of complication and ease the symptoms. Paracetamol, ibuprofen, aspirin can be used to reduce high temperature and treat acne and pain.

High risk of complication in rubella infected pregnant women and the larger number of unvaccinated children & adults are the major factors which contribute to the growth of rubella treatment market. Increasing manufacturers focus on drug development for rare diseases, rising healthcare awareness, government programs to maintain pregnant women health are expected to be some other factor which propels the growth of rubella treatment market. Failure to vaccinating children against measles & rubella puts them at risk of severe health complications, such as brain damage, deafness, and blindness. Increasing failure of vaccination will boost the demand of drugs which are used for symptomatic treatment and, can indirectly contribute in the growth of rubella treatment market. No specific treatment is available for rubella infection, which is a major factor hampering the growth of rubella treatment market.

For Information On The Research Methodology request here @ https://www.persistencemarketresearch.com/methodology/23029

The global rubella treatment market is segmented on basis of drug type, route of administration and distribution channel:

  • Segmentation by Drug Type
    • Nonsteroidal Anti-Inflammatory Drugs
    • Analgesic
  • Segmentation by Route Of Administration
    • Oral
    • Topical
  • Segmentation by End User
    • Hospital Pharmacies
    • Drug Stores
    • Online Pharmacies
    • Retail Pharmacies

To receive extensive list of important regions, Request TOC here @ https://www.persistencemarketresearch.com/toc/23029

Nonsteroidal anti-inflammatory drugs and analgesic drugs are used for rubella treatment or reduce symptoms. These drugs provide ease of pain, reduce itching and control fever due to rubella infection. Rubella infection is dangerous during pregnancy if a woman contract rubella up to 13 week of pregnancy there is a very high risk that baby can be affected with measles. Baby can develop problems such as sight or hearing loss.

Regionally, the global rubella treatment market is segmented into six key regions viz. North America, Latin America, Europe, Asia Pacific Excluding China, China, and Middle East & Africa. North America is expected to lead the global market due to increasing drug manufacturing facilities and high awareness regarding infectious diseases. Europe also shows second highest growth in rubella treatment market due to strong laws and government guidelines regarding child and mother health. Moreover, the rubella treatment market in the Asia-Pacific region is expected to witness significant growth rate during the forecast period due to increasing government initiatives to reduce disease complication in children. More than 60% of the 21.5 million children who did not receive one dose vaccination in 2013 come from 6 counties India, Nigeria, Pakistan, Ethiopia, Indonesia, DR Congo.

Some of the players operating in the global rubella treatment market are Bayer AG, Novartis AG, Pfizer Inc., Johnson & Johnson, GlaxoSmithKline PLC., Reckitt Benckiser Group plc, Endo International plc, Bristol-Myers Squibb, Eli Lilly and Company, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Merck & Company, Inc., Perrigo Company plc, Abbott Laboratories, Geri-Care Pharmaceuticals Corp., Kopran Ltd. and others.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Tanvi Birajdar
Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com

Categories
All News News

Global Non Union Fractures Market to Witness Rapid Development During the Period 2018 – 2026

Nonunion bone fracture is changeless disappointment of recuperating following a broken bone unless intercession, (for example, surgery) is performed. Nonunion fractures can be categorized into hypertrophic (generally due to mechanical failure/ callus formation) and atrophic (generally due to organic failure/ no callus and bone resorption). A delayed or with nonunion fracture forms a structural resemblance to a fibrous joint, and is therefore often called pseudoarthrosis. Nonunion fracture is a genuine complexity of a bone fracture and may happen when the bone moves excessively, has a poor blood supply or gets infected. Patients who smoke have a higher occurrence of nonunion fractures. The ordinary procedure of bone recuperating is hindered or slowed down.

For more insights into the Market, request a  sample of this report @ https://www.persistencemarketresearch.com/samples/23059

A nonunion or delayed fracture may go ahead to recuperate without mediation in many cases. In normal, if a nonunion is as yet obvious at a half year post damage it will stay unhealed without particular treatment, generally orthopedic surgery. The revision surgical intervention is the common methodology utilized, treatment via stem cell therapies is also on a rise, such as, Regenexx stem cell procedure. The explanations for a non-union fracture may comprise: complicated, multisegmental fractures (severe comminution), open fractures, fractures associated with tumors (pathologic fractures), infection, inadequate fracture immobilization (fixation), inadequate blood supply, poor nutrition, and chronic disease states (diabetes, renal failure, metabolic bone disease).

For Information On The Research Methodology request here @ https://www.persistencemarketresearch.com/methodology/23059

Factors Driving Non-union fractures

Increasing sports related injuries and mechanical injuries, diabetic population, obesity, bone infection, poor nutrition and rising pathologic fractures among geriatric individuals is going to spur revenue growth for global non-union fractures market. In the US, there are roughly seven million new fractures which occur every year, with around 300,000 growing gradually. Appraisals for the normal non-union fracture associated treatment cost shift from almost $25,000 to $45,000. Non-unions are assessed to cost the healthcare services in the US $9.2 billion/year. This prohibits losses in profitability to the economy.

To receive extensive list of important regions, Request TOC here @ https://www.persistencemarketresearch.com/toc/23059

Rising Associated Cost for Non-union fractures Treatment

In the UK, there are around 850,000 new bone fractures seen every year. While it has been recommended that roughly 5-10% of such fractures are fractures in which the broken bone neglects to recuperate, medicinally alluded to as nonunion bone fractures. The cost to the National Health Service of treating non-union bone fractures has been accounted for to go amongst £18,000 and £79,000 per individual. The evaluated addressable market for nonunion and improved recuperating of bone fractures for the EU is around 0.7 to 2 Bn Euros for each year, expecting a cost of roughly 2,000 to 2,500 Euro for every treatment regimen. Normal direct expenses of treatment for a built up long bone non-union have been accounted for: Canada, $11,800; the USA $11,333; the UK £29,204.

Market Segmentation:

By Treatment Type

  • Surgery
  • Stem Cell Therapy
  • Others

By Indication

  • Infection
  • Open fractures
  • Fractures associated with tumors (pathologic fractures)
  • Chronic disease states (diabetes, renal failure, metabolic bone disease)
  • Others

Regional Market Outlook

Globally, around 50 Mn bone fractures occur worldwide consistently. Osteoporosis is the most widely recognized reason for bone fractures and the commonness of osteoporosis and low bone mass is required to increment in coming a very long time due basically to the geriatric and matured population. Roughly 33% of all tibia and femoral shaft bone fractures have deferred rates of recuperating or non-healing. Patients with postponed union or non-union can expect poorer results, including expanded pain, loss of overall functionality, loss of personal satisfaction, and deferral consequently to work. There are as of now restricted treatment alternatives accessible for enhancing the rate of bone healing and bone fracture repair. Anabolic specialists and bone morphogenetic proteins, including teriparatide, are exorbitant and may need wanted viability; enhanced therapeutic or remedial choices are desired. On the basis of geography, the global non-union fractures market can be segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa. North America and Europe collectively are expected to dominate the global non-union fractures market due to increasing awareness and inclination of treatment options coupled with stem cell therapy management. However, APAC is expected to grow at a sluggish rate in the global market due to their low adoption, though with large patient pool. The Middle East & Africa to adopt this advanced technology lately due to less awareness and less reach of the product due to less geographical presence of the players.

Competition Outlook

Examples of some of the key participants in the non-union fractures market are Daniel C. Allison, Regenexx, Kalytera Therapeutics, Inc., ASA srl, Mesentech, EnteraBio Ltd. and others.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Tanvi Birajdar
Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com

Categories
All News News

Rapid Advancements in Ischemic Optic Neuropathy Treatment Market to Fuel Revenues Through 2026

Ischemic optic neuropathy is caused due to a small vessel infraction of the optic nerve and is a major cause of blindness or impaired vision among the inflicted. There are two types of ischemic optic neuropathies viz. anterior ischemic optic neuropathy and posterior or non-anterior ischemic optic neuropathy. Anterior ischemic optic neuropathy is caused by the inflammation of arteries supplying blood to the optic nerve whereas posterior or non-anterior ischemic optic neuropathy is caused due to reasons other than inflammation of the arteries. Anterior ischemic optic neuropathy is more prevalent as compared to posterior ischemic optic neuropathy.

For more insights into the Market, request a  sample of this report @ https://www.persistencemarketresearch.com/samples/23077

In anterior ischemic optic neuropathy, immediate treatment is required to prevent vision loss in the fellow eye as approximately 50 percent of cases have chances of blindness in another eye within a span of 5 to 10 days without treatment. The symptoms of ischemic optic neuropathy include unilateral, acute and painless visual loss for hours to days. Hypertension, diabetes, and hypercholesterolemia are some of the well-known risk factors associated with ischemic optic neuropathy disease. Other factors include generalized hypoperfusion, sleep apnea, nocturnal hypotension, vasospasm, severe anemia and failure of autoregulation.

Technological advancements in ischemic optic neuropathy treatment and availability of alternative drugs are anticipated boost the demand for ischemic optic neuropathy treatments over the forecast period.

For Information On The Research Methodology request here @ https://www.persistencemarketresearch.com/methodology/23077

The global ischemic optic neuropathy treatment market can be segmented on the basis of disease type, treatment type and end user.

On the basis of disease type, the global ischemic optic neuropathy treatment market can be segmented into:

  • Anterior Ischemic Optic Neuropathy
    • Arteritic
    • Nonarteritic
    • Perioperative
  • Posterior Ischemic Optic Neuropathy
    • Arteritic
    • Nonarteritic
    • Perioperative

On the basis of treatment type, the global ischemic optic neuropathy treatment market can be segmented into:

  • Medication
    • Corticosteroids
    • Anti-VEGF
    • Immunosuppressants
    • Biologics
  • Surgery

On the basis of end user, the global ischemic optic neuropathy treatment market can be segmented into:

  • Hospitals
  • Clinics
  • Ophthalmology Centers
  • Others

To receive extensive list of important regions, Request TOC here @ https://www.persistencemarketresearch.com/toc/23077

The global ischemic optic neuropathy treatment market is expected to register a significant CAGR over the forecast period. The increasing adoption of recently approved intravitreal implants in the treatment of ophthalmology diseases is anticipated to propel the growth of the ischemic optic neuropathy treatment market over the forecast period. Leading pharmaceutical and drug manufacturing companies from developed countries are substantially investing in R&D, infrastructure and new technologies in ophthalmology therapeutics to capture a market share in the growing burden of eye diseases, which also boosts the growth of the global ischemic optic neuropathy treatment market. With growing awareness towards eye-related complications that lead to blindness, geriatric population and diabetic patients in developed countries, such as the U.S., Russia, and Poland, Germany and Japan are seen to have a proactive approach for treatment related to complications rather than reactive treatment, which also bolsters the growth of the market of ischemic optic neuropathy treatment.

Corticosteroid is the first choice of therapy for patients with ischemic optic neuropathy in prominent countries, such as the U.S., Germany, France, and Russia; however, a majority of patients have developed resistance to anti-VEGF, which leads to the adoption of alternative therapy in patients with ischemic optic neuropathy. This is anticipated to drive the growth of the global ischemic optic neuropathy treatment market in the long run.

However, medications such as intravitreal injections of anti-VEGF drugs and corticosteroids lead to an instant increase in intraocular pressure, which may lead to severe adverse effects such as conjunctival haemorrhage, eye pain, cataract, vitreous floaters, intraocular pressure increased and vitreous detachment. This may restrain the growth of the global ischemic optic neuropathy treatment market.

On the basis of regional presence, the global ischemic optic neuropathy treatment market can segmented into five key regions, namely North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa.

North America is a dominant region in the market and contributes a leading share to the global ischemic optic neuropathy treatment market in terms of revenue. The market in the region is expected to register significant growth over the forecast period due to the availability of developed medical infrastructure and treatment facilities in the region. Europe also contributes a moderate share and registered a healthy growth rate in the global ischemic optic neuropathy treatment market. The APEJ region has become a lucrative market for ischemic optic neuropathy treatment and is anticipated to register a significant share over the forecast period, due to the increase in research and development activities along with the growth in medical tourism in the region. Latin America and MEA are in the nascent stage in the global ischemic optic neuropathy treatment market and are expected to register moderate growth over the forecast period.

Some of the market players operating in the ischemic optic neuropathy treatment market include Allergan, Plc., Pfizer, Inc., Novartis AG, F. Hoffman – La Roche Ltd., AbbVie Inc., Bayer AG, Valeant Pharmaceuticals Inc., Alimera Sciences Inc. and Amgen, Inc.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Tanvi Birajdar
Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com

Categories
All News Coronavirus News

The Amniotic Fluid Stem Cell Therapy Market to generate “Multi-faceted” revenue between 2018 and 2026

Stem cells are biological cells which have the ability to distinguish into specialized cells, which are capable of cell division through mitosis. Amniotic fluid stem cells are a collective mixture of stem cells obtained from amniotic tissues and fluid. Amniotic fluid is clear, slightly yellowish liquid which surrounds the fetus during pregnancy and is discarded as medical waste during caesarean section deliveries. Amniotic fluid is a source of valuable biological material which includes stem cells which can be potentially used in cell therapy and regenerative therapies. Amniotic fluid stem cells can be developed into a different type of tissues such as cartilage, skin, cardiac nerves, bone, and muscles. Amniotic fluid stem cells are able to find the damaged joint caused by rheumatoid arthritis and differentiate tissues which are damaged.

For more insights into the Market, request a  sample of this report @ https://www.persistencemarketresearch.com/samples/23101

Medical conditions where no drug is able to lessen the symptoms and begin the healing process are the major target for amniotic fluid stem cell therapy. Amniotic fluid stem cells therapy is a solution to those patients who do not want to undergo surgery. Amniotic fluid has a high concentration of stem cells, cytokines, proteins and other important components. Amniotic fluid stem cell therapy is safe and effective treatment which contain growth factor helps to stimulate tissue growth, naturally reduce inflammation. Amniotic fluid also contains hyaluronic acid which acts as a lubricant and promotes cartilage growth.

With increasing technological advancement in the healthcare, amniotic fluid stem cell therapy has more advantage over the other therapy. Amniotic fluid stem cell therapy eliminates the chances of surgery and organs are regenerated, without causing any damage. These are some of the factors driving the growth of amniotic fluid stem cell therapy market over the forecast period. Increasing prevalence of chronic diseases which can be treated with the amniotic fluid stem cell therapy propel the market growth for amniotic fluid stem cell therapy, globally. Increasing funding by the government in research and development of stem cell therapy may drive the amniotic fluid stem cell therapy market growth. But, high procedure cost, difficulties in collecting the amniotic fluid and lack of reimbursement policies hinder the growth of amniotic fluid stem cell therapy market.

For Information On The Research Methodology request here @ https://www.persistencemarketresearch.com/methodology/23101

The global amniotic fluid stem cell therapy market is segmented on basis of treatment, application, end user and geography:

  • Segmentation by Treatment
    • Allogeneic Amniotic Fluid stem cell therapy
    • Autologous Amniotic Fluid stem cell therapy
  • Segmentation by Application
    • Regenerative medicines
      • Skin
      • Orthopedics
      • Oncology
      • Fetal tissue reconstruction
      • Kidney regeneration
      • Regeneration of neural tissue
      • Cardiac regeneration
      • Lung epithelial regeneration
      • Others
    • Drug research and development
  • Segmentation by End User
    • Hospital
    • Ambulatory Surgical Centers
    • Specialty Clinics
    • Academic and Research Institutes
  • Segmentation by Geography
    • North America
    • Latin America
    • Europe
    • Asia-Pacific Excluding China
    • China
    • Middle East & Africa

To receive extensive list of important regions, Request TOC here @ https://www.persistencemarketresearch.com/toc/23101

Rapid technological advancement in healthcare, and favorable results of the amniotic fluid stem cells therapy will increase the market for amniotic fluid stem cell therapy over the forecast period. Increasing public-private investment for stem cells in managing disease and improving healthcare infrastructure are expected to propel the growth of the amniotic fluid stem cell therapy market.

However, on the basis of geography, global Amniotic Fluid Stem Cell Therapy Market is segmented into six key regions viz. North America, Latin America, Europe, Asia Pacific Excluding China, China and Middle East & Africa. North America captured the largest shares in global Amniotic Fluid Stem Cell Therapy Market and is projected to continue over the forecast period owing to technological advancement in the healthcare and growing awareness among the population towards the new research and development in the stem cell therapy. Europe is expected to account for the second largest revenue share in the amniotic fluid stem cell therapy market. The Asia Pacific is anticipated to have rapid growth in near future owing to increasing healthcare set up and improving healthcare expenditure. Latin America and the Middle East and Africa account for slow growth in the market of amniotic fluid stem cell therapy due to lack of medical facilities and technical knowledge.

Some of the key players operating in global amniotic fluid stem cell therapy market are Stem Shot, Provia Laboratories LLC, Thermo Fisher Scientific Inc. Mesoblast Ltd., Roslin Cells, Regeneus Ltd. etc. among others.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Tanvi Birajdar
Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com

Categories
All News Coronavirus News

The Off Loading Devices Market to Transcend the “Covid-19” Barrier from 2021 onwards

Off-loading devices are used to reduce the body pressure on ulcerogenic callus in diabetic patients, which is developed due to poor circulation, lack of feeling in the foot, foot deformities or trauma. These devices aim to eliminate the abnormal pressure points and promote healing. There are two types of off-loading devices such as footwear and total contact casts which vary in cost and effectiveness. Both devices also have their advantages and disadvantages. The effect of these devices also varies from person to person depending on their diabetic condition and use of the device. Off-loading devices are designed in order to be used in post-surgical healing, forefoot trauma, wound, ulceration or any situation requiring a pressure off-load of the forefoot.  These devices are not only used for the treatment purpose but also used for the prevention of diabetic foot ulcers. The science behind the use of off-loading devices lies with the understanding of biomechanics and shear forces responsible for diabetic foot ulcers. The need for off-loading devices has increased in patients who along with diabetes are also suffering from obesity.

For more insights into the Market, request a  sample of this report @ https://www.persistencemarketresearch.com/samples/23113

Advantages in wound healing technology have greatly expanded the ability to effectively manage diabetic foot ulcers and prevent the chances of lower extremity amputations. 85% of the lower extremity amputations are preceded by a diabetic foot ulcer and can be preventable. Use of off-loading devices also has the potential to substantially reduce the overall healthcare burden of diabetic foot ulcers.

Off-Loading Devices Market: Drivers & Restraints

Improvement in the concerns about diabetes management, screening and foot care promote the use of off-loading devices. Also, rise in the number of diabetic population globally which is now more than 450 million may also lead to the increase in the cases of diabetic foot ulcers, thus fuelling the adoption of off-loading devices. In addition to this, increase in the availability as well as variability of off-loading devices also promotes the market growth. Some of the factors limiting the market include ignorance of diabetic foot care and associated high cost of the equipment. Unavailability of these assisting products in the under-developed and developing countries as well as poor diabetic management restrict the global market growth of off-loading devices.

For Information On The Research Methodology request here @ https://www.persistencemarketresearch.com/methodology/23113

Off-Loading Devices Market: Segmentation

By Product Type

  • Off-loading Footwear
  • Total Contact Casts

By Distribution Channel

  • Hospitals
  • Specialized Clinics
  • Healthcare Stores
  • Online Stores

To receive extensive list of important regions, Request TOC here @ https://www.persistencemarketresearch.com/toc/23113

There are currently numerous off-loading devices that are available varied by the material used, complexity and cost. Total contact cast off-loading devices have better healing properties but they are more costly than the footwear and not afforded by all. Opportunity for market players lies with the expanding their product range based on the off-loading capabilities and further research. There is a growing need for off-loading devices and the market opportunity lies in the development of economical and easy to wear devices.

Off-Loading Devices Market: Regional Outlook

Geographically, the market for off-loading devices can be segmented into five regions, North America, Latin America, Europe, Asia Pacific and Middle East & Africa. North America is expected to have high share in the global off-loading devices market owing to the available funding by federal and state government as well as favorable reimbursement scenarios. This is followed by the European market because of the developed healthcare infrastructure, routine healthcare check-ups and awareness about the disease. This is followed by the Asia-Pacific market. It represents a huge market potential, however several factors restrict the market growth in this region. Latin America followed by MEA is expected to have the least market share and growth rate over the forecast period due to the non-availability of these services in most of the countries as well as poor healthcare infrastructure.

Off-Loading Devices Market: Key Players

Examples of some of the key players in the global off-loading devices market are DARCO International, PulseFlow Technologies, Hollister Incorporated, BSN medical, Integra Life Sciences Corp., Posey Products, LLC, DeRoyal Industries, Inc., DM Systems, Inc., PPL Biomechanics, and Repton Medical, among others.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Tanvi Birajdar
Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com

Categories
Coronavirus News

The Infection Surveillance Solutions Market To Display Growth In Revenue By 14.04% Between 2025

Market Report Summary 

  • Market – Infection Surveillance Solutions Market 
  • Market Value – US$ 905 Mn in 2025 
  • Market CAGR Value – 14.04% in 2025 
  • Market Forecast Year – 2020 to 2030 

For Full Information ->  Click Here 

Read Full Press Release Below

Infection surveillance solution helps healthcare facilities in reporting patient-associated data to the state and federal authorities. Integration of infection surveillance software with already existing networks of medical facilities and hospitals is an easy process.

A recent report published by Persistence Market Research (PMR) estimates the global infection surveillance solution market to register a staggering 14.04% CAGR during the forecast- 2017 to 2025. The US$ 316.67 Mn market is likely to surpass US$ 900 Mn in revenues by 2025-end.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/13543

Company Profiles

  • Becton Dickson & Company
  • Baxter International
  • Premier, Inc.
  • Truven Health Analytics Inc. (IBM Watson)
  • Gojo Industries, Inc.
  • RL Solutions
  • Wolters Kluwer N.V.
  • Vigilanz Corporation
  • Atlas Medical Software (Rpoer Technologies)
  • Quantros, Inc.
  • BD Diagnostics
  • ICNet Systems, Inc. (Baxter International)
  • Vecna Technologies, Inc.
  • bioMerieux, Inc.
  • Hygreen Inc.
  • Emerald Health Information Systems Ltd
  • DEB Group Ltd.
  • Iatric Systems, Inc.
  • PeraHealth Inc.
  • Cerner Corporation
  • Others.

Contamination of devices & equipment, patient clothing, and bed linens have led to various hospital-associated infections including pneumonia, urinary tract infection, and surgical site infection. To identify the possible healthcare associated infections, hospitals and healthcare professionals are being impelled to adopt infection surveillance systems.

Healthcare institutes are incorporating infection surveillance systems to seek accurate, real-time information related to medical records, surgical database, employees’ health and patient health. The aforementioned factors are driving the growth of the global infection surveillance solution market.

Governments of various economies are encouraging health communication programs within health institutes. These governments are coming up with initiatives for building a reliable data source. This further would help in exchanging information within healthcare systems.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/13543

In addition, the capacity of IT systems is witnessing a surge in performing analytic processing. These factors are expected to aid in the development of analytical and infection surveillance solutions. However, improper data management, soaring volume of data for analysis coupled with altering regulatory requirements, and rising trend of healthcare staff migration on international level are key restrains expected to inhibit the market growth over the forecast period.

Hospitals to be the Most Lucrative End User in the Market

Among end users, hospitals will be the most lucrative in the global infection surveillance solution market. Revenues amassed from hospitals would reach around US$ 500 Mn by 2025-end. Clinics, the second largest end-user, are expected to exhibit 14.19% CAGR through 2025.

Although software component is projected to be most lucrative over the global infection surveillance solution market, the services component is projected to register a comparatively faster growth during the forecast period. Infection and surveillance software enables clinics and hospitals to minimize and control healthcare-associated infections in real-time.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/13543

North America to be Dominant in the Global Infection Surveillance Solution Market

PMR’s report projects North America to remain dominant in the market during the forecast period, followed by Europe and Asia Pacific (APAC).

The United States (U.S.) is expected to be the most lucrative country in North America infection surveillance solution market. Federal regulation in North America have driven the adoption of infection surveillance solutions by hospitals and other healthcare settings.

Europe and APAC are anticipated to exhibit 13.86% and 13.10% CAGRs respectively through 2025. Government initiatives and programs in Europe, for example- European Influenza Surveillance Scheme by European Center for Disease and Prevention Control, are fuelling the growth of the market in this region.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR’s collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish Kolte
Persistence Market Research
Address – 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]
Website – https://www.persistencemarketresearch.com